# J. Jean Cui

> J. Jean Cui is the San Diego-based scientific co-founder, president and CEO of BlossomHill Therapeutics, and previously co-founded Turning Point Therapeutics. Trained in organic chemistry at Ohio State after bachelor’s and master’s studies at the University of Science and Technology of China, she worked at SUGEN and Pfizer before founding companies. She was elected to the National Academy of Engineering in 2024; BlossomHill began Nasdaq trading in August 2026.

- **Role:** Scientific Founder, President and CEO at BlossomHill Therapeutics, Inc.
- **Organizations:** BlossomHill Therapeutics, Inc., Turning Point Therapeutics, Inc., Pfizer, SUGEN, Inc., Glycomed, Inc., National Academy of Engineering
- **Education:** Bachelor of Science in Chemistry, University of Science and Technology of China, Master of Science in Chemistry, University of Science and Technology of China, Ph.D. in Organic Chemistry; doctoral mentor Derek Horton, The Ohio State University, Postdoctoral training, Lawrence Berkeley National Laboratory and University of California, Berkeley
- **Known for:** National Academy of Engineering election, 2024, ACS Heroes of Chemistry honoree, 2013 and 2021, 38th Annual Inventor of the Year Award with Pfizer chemistry team, 2011

## Career timeline

- **1995** — Entered industry; identified Glycomed as her first employer.
- **1999-2003** — Project leader and group leader at SUGEN.
- **2003-2013** — Senior principal scientist and associate research fellow at Pfizer in La Jolla.
- **2013** — Co-founded Turning Point Therapeutics with Y. Peter Li.
- **2019** — Turning Point went public on Nasdaq in April.
- **2020** — Left Turning Point’s CSO role early in the year; co-founded BlossomHill in June.
- **2022** — Turning Point acquired by Bristol Myers Squibb for $4.1 billion, after her departure.
- **2024** — Elected to the National Academy of Engineering; BlossomHill announced a $100 million Series B.
- **2026** — BlossomHill began Nasdaq trading on August 7 under BLSM.

## Achievements

- National Academy of Engineering election, 2024
- ACS Heroes of Chemistry honoree, 2013 and 2021
- 38th Annual Inventor of the Year Award with Pfizer chemistry team, 2011
- Pfizer Worldwide R&D Achievement Awards, 2006 and 2012
- Pfizer Innovation Award, 2011
- Ohio State Distinguished Alumni Achievement Award, 2022
- San Diego BioPharma Achievement Award from SABPA, 2022
- ACS San Diego Distinguished Scientist Award, 2023
- Committee of 100 Circle of Excellence Award in Humanity in Science & Technology, 2023
- Inaugural CABS K. Fong Award in Life Sciences, 2013

## Latest updates

- **2026-09** — Appeared in a BiotechTV interview at the H.C. Wainwright investment conference, published September 16.
- **2026-08** — BlossomHill priced an upsized $150 million IPO and began trading on Nasdaq on August 7 under BLSM.

## Links

- Website: https://bhtherapeutics.com/team/j-jean-cu/
- LinkedIn: https://www.linkedin.com/in/j-jean-cui-9b83a817
- Twitter/X: https://x.com/jjeancui

---

Profile page: https://yespress.io/j-jean-cui
Published by YesPress — https://yespress.io
Last updated: 2026-10-15